HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ya-Ni Liu Selected Research

Ralfinamide

8/2021Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ya-Ni Liu Research Topics

Disease

2COVID-19
01/2022 - 01/2021
1Drug-Related Side Effects and Adverse Reactions
05/2022
1Adenocarcinoma of Lung
05/2022
1Neuralgia (Stump Neuralgia)
08/2021
1Pain (Aches)
08/2021
1Chronic Pain
08/2021
1Bicuspid Aortic Valve Disease
01/2018
1Acute Coronary Syndrome
07/2013
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2013
1Retinitis pigmentosa 1
01/2013
1Atherosclerotic Plaque (Atheroma)
05/2009

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2021
2Contrast MediaIBA
07/2013 - 05/2009
1PlatinumIBA
05/2022
1Pemetrexed (MTA)FDA Link
05/2022
1RalfinamideIBA
08/2021
1Formaldehyde (Formol)FDA Link
08/2021
1Voltage-Gated Sodium ChannelsIBA
08/2021
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2018
1Matrix Metalloproteinases (MMPs)IBA
01/2018
1Rhodopsin (Visual Purple)IBA
01/2013

Therapy/Procedure

1Drug Therapy (Chemotherapy)
05/2022
1Therapeutics
08/2021
1Microbubbles
05/2009